series b

presented by
Daily

Aldea raises $24M for drug that targets severe drunkenness

This one’s a hair better than, ah, the hair of the dog: Aldea Pharmaceuticals’ drug for acute alcohol intoxication is advancing into clinical trials, thanks to a sizable new round of funding. The new drug’s meant to be intravenously administered to emergency room patients with alcohol poisoning. The company just closed out a $24 million Series […]

Daily

New-wave insulin maker Thermalin Diabetes raises $5.9M

Thermalin Diabetes is picking up steam – and funding – as it develops a more concentrated and faster-acting version of insulin. The Boston and Cleveland-based company just raised $5.9 million from private investors in the first tranche of a Series B round. To date, it has raised about $15 million in equity and $8 million in NIH […]